Medigrow is a biotechnology and pharmaceutical company focused on the cultivation, processing, and export of medical-grade cannabis products. Licensed in 2018, the company operates a state-of-the-art facility in Lesotho, utilizing the region's ideal climate to produce high-quality cannabis flower and extracts. Medigrow adheres to Good Manufacturing Practices (GMP) to ensure its products meet the stringent standards required for international pharmaceutical markets, with a mission to supply patients worldwide with safe and effective cannabinoid-based medicines.

Founded in

Australia